5-Ht1b/1d Agonists has 2 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Eletriptan Hydrobromide, Zolmitriptan. Patients taking 5-Ht1b/1d Agonists should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Contraindicated
- 2
Contraindicated (2)
- 5-Ht1b/1d Agonists + Eletriptan Hydrobromide— Concomitant use of other 5-HT1 agonists within 24 hours of eletriptan hydrobromide treatment is contraindicated.
- 5-Ht1b/1d Agonists + Zolmitriptan— Concomitant use of other 5-HT1B/1D agonists (including triptans) within 24 hours is contraindicated due to risk of addit…